Treatment Response Assessment and Retreatment Decision Making
Diana Horvath-Rizea, MD, from the Clinic for Neuroradiology at Klinikum Stuttgart, Germany, discusses treatment response assessment and re-treatment decision-making using Brainlab Elements Contrast Clearance Analysis. She describes how the methodology works by subtracting an early from a late T1 scan from which the Contrast Clearance Analysis image is generated. She then compares Contrast Clearance Analysis to perfusion MRI, discussing specificity and sensitivity. Finally, she provides case examples from her institution to demonstrate the methodology and results.
Targets, tracts, tumors and trouble – Why Brainlab is an essential element for a successful brain radiosurgery program
Expert demo session: Elements Multiple Brain Mets SRS 3.0
Novalis Circle technical webinar: Elements Multiple Brain Mets SRS
Multiple Brain Metastases SRS for small targets – simple case
Trajectory Based Treatment Planning and Delivery for Cranial Radiosurgery
Reporting Clinical Outcomes via the NeuroPoint Alliance National...
Advanced MR and PET Imaging: Is it Really Useful in Brain Tumor Radiosurgery?
Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login